Centre for Molecular Medicine and Biobanking, Biomedical Sciences Building, University of Malta, Msida, Malta.
Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
Eur J Hum Genet. 2022 Jul;30(7):856-859. doi: 10.1038/s41431-021-00975-x. Epub 2021 Oct 7.
Amyotrophic lateral sclerosis (ALS) is frequently caused by mutations in the SOD1 gene. Here, we report the first SOD1 variant in Malta, an archipelago of three inhabited islands in southern Europe. We describe a patient with a sporadic form of ALS living on the island of Gozo in which the heterozygous SOD1 c.272A>C; p.(Asp91Ala) variant was detected. The patient had a late onset (79 years), sensory impairments and rapid disease progression culminating in respiratory failure. ALS has not yet developed in any of the three additional family members in which the D91A variant was identified. None of the healthy controls from the Maltese population were found to carry this variant. This report underscores the high prevalence of the D91A variant in Europe, despite the presence of a North-South gradient in its frequency, and confirms that this variant can be associated with dominant cases in Mediterranean countries.
肌萎缩侧索硬化症(ALS)常由 SOD1 基因突变引起。在这里,我们报告了首例在马耳他发现的 SOD1 变异,马耳他是欧洲南部三个有人居住的岛屿组成的群岛。我们描述了一位居住在戈佐岛的散发型 ALS 患者,其 SOD1 c.272A>C;p.(Asp91Ala)杂合变异被检出。该患者发病较晚(79 岁),存在感觉障碍,疾病快速进展,最终导致呼吸衰竭。在另外三名已确定携带 D91A 变异的家族成员中,尚未出现 ALS。在来自马耳他人群的健康对照者中,未发现该变异。本报告强调了 D91A 变异在欧洲的高流行率,尽管其频率存在南北梯度,并且证实该变异可与地中海国家的显性病例相关。